Abstract:Thank you for submitting your manuscript on Smad3 monoubiquitination by Smurf2 for consideration by The EMBO Journal. We have now received the comments of three expert reviewers, copied below. While the referees consider your findings potentially interesting and the study overall well-done, they however raise serious concerns regarding the conclusiveness of the data and the experimental support for the main conclusions. The extent of this criticisms, I am afraid to say, appears to preclude publication in The EMBO Journal, at least in the present form. Nevertheless, given the interest in principle, I am willing to give you an opportunity to respond to the referees' criticisms through a revised version. It is however clear that for the manuscript to eventually become suitable for publication in these pages, a significant amount of revision effort will be required, and I also realize that not all of the requested manuscript may be technically feasible I would therefore also understand if you were to decide to rather publish the manuscript rapidly and without major changes elsewhere. Should you however decide to thoroughly revise the study for The EMBO Journal, I would in fact not insist on clarification of the underlying genetic redundancies among Smad-regulating ubiquitin ligases, nor on the absence of mouse phenotypes. What would however be absolutely required is a thorough mechanistic clarification on the cellular level, in particular to show that Smad3 is regulated by Smurf2 on the endogenous level in the absence of exogenous overexpression. It will also be essential to address the question of monovs. multi-monovs. poly-ubiquitination raised by all referees, and to clarify the impact of Smurf2 on Smad2 relative to Smad3. Finally, the referees are unconvinced by the present evidence for Smad3 monoubiquitination affecting signaling via complex disruption, and more compelling data will be needed to address this.

Wnt-Induced Deubiquitination FoxM 1 Abrogates the Inhibition of ICAT to β-catenin transactivation

XIAP inhibits autophagy via XIAP-Mdm 2p 53 signaling

Wnt‐induced deubiquitination FoxM1 ensures nucleus β‐catenin transactivation

Inhibition of Autophagy by a Small Molecule Through Covalent Modification of the LC3 Protein

FoxM 1 , USP 5 , and ICAT in Wnt / b-catenin signaling

Correction to: USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Ablation of Smurf 2 reveals an inhibition in TGF-β signaling through mono-ubiquitination of Smad 3

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

USP10 strikes down 8-catenin by dual-wielding deubiquitinase activity and phase separation potential

USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential

Erratum: LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction (LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction (2013) 5(6) (1650–1663), (S2211124713007213), (10.1016/j.celrep.2013.11.037))

RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

Correction: A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination

Erratum: the FoxO–BNIP3 Axis Exerts a Unique Regulation of Mtorc1 and Cell Survival under Energy Stress

Author Correction: Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes β-catenin palmitoylation to drive colorectal cancer progression

Title : Leucine-rich Repeat Kinase 2 regulates Sec 16 A at ER exit sites to allow ER-Golgi export

Abstract 5214: Functional Interaction Between Foxm1 and Β-Catenin

Direct Targeting of Β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.

Chemical Biology Reveals CARF As a Positive Regulator of Canonical Wnt Signaling by Promoting TCF/β-catenin Transcriptional Activity

Correction to: Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2